Product Code: A16857
The home rehabilitation product market size was valued at $22,384.0 million in 2020, and is projected to reach $43,599.3 million by 2031, registering a CAGR of 7.1% from 2022 to 2031. The home rehabilitation market is meant to provide products that are used to restore sensory, physical, and mental abilities of patients who are suffering from such conditions due to injuries and chronic diseases. The main aim of the home rehabilitation product market is to improve health of patients within home care settings.
The major factors that drive growth of the home rehabilitation product market include decrease in treatment cost, increase in patient comfort, and rise in efficiency of rehabilitation products. In addition, increase in demand for home rehabilitation products among many healthcare institutes such as Apollo hospitals to provide rehabilitation services at patient's doorstep lead to growth of the market. Moreover, rise in demand for innovative and advanced rehabilitation facilities, coupled with rise in aging population further contributes toward the increasing demand. After the COVID-19 pandemic, the market witnessed substantial increase in sales of home rehabilitation products, majorly wheelchairs and other products that include medical beds and stretchers.
The market in North America dominates the global home rehabilitation product market, owing to increase in adoption of new technologies such as wheelchairs, mobility vehicles, and tricycles. Developed healthcare infrastructure, efficiency of home rehabilitation products along with the rise in musculoskeletal disorders in the region have made a good impact to the home rehabilitation product market.
Several other regions such as Asia-Pacific which includes China, India, Indonesia, and Thailand are witnessing higher demand for home rehabilitation products, owing to reduced treatment cost and implementations of government campaigns for awareness of rehabilitation products, which propels growth of the market in the region.
Moreover, increase in volume of patients suffering from different chronic disorders, escalation in number of persons with disabilities, rise in incidences of disabilities, and increase in long-term care centers with major demand for such kinds of products among adult patients majorly drive the market growth. However, lack of adoption in low-income countries is anticipated to hamper the market growth during the forecast period.
The global home rehabilitation products market is segmented into product type, patient type, end user, and region. On the basis of product type, the market is categorized into wheelchairs, general aids, body support devices, positioning devices, and others. On the basis of patient type, the market is bifurcated into adult, and pediatric. On the basis of end user, the market is segmented into hospitals, long term care centers, outpatient centers, medical research institutes, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, The Netherlands, Switzerland and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Thailand, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East & Africa).
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the home rehabilitation products market analysis from 2021 to 2031 to identify the prevailing home rehabilitation products market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the home rehabilitation products market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global home rehabilitation products market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product type
- Wheelchairs
- General aids
- Body support device
- Positioning device
- Others
By Patient type
By End user
- Hospitals
- Long term care centers
- Outpatient centers
- Medical research institutes
- Others
By Region
- North America
- Europe
- UK
- Italy
- Germany
- France
- Spain
- The Netherlands
- Switzerland
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
- Key Market Players
- Medline Industries, Inc.
- Stryker Corporation
- Invacare Corporation
- DJO Global
- Ekso Bionics Holdings, Inc.
- RehabCare
- Active Medical and Rehabilitation Services Pvt. Ltd.
- ergoline GmbH
- Performance Health
- Baxter International
- Arjo
- Colfax Corp
- Dynatronics Corp.
- Handicare Group AB
- Drive DeVilbiss International
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- 3.7.Value Chain Analysis
CHAPTER 4: HOME REHABILITATION PRODUCTS MARKET, BY PRODUCT TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Wheelchairs
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 General aids
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Body support device
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Positioning device
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Others
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
CHAPTER 5: HOME REHABILITATION PRODUCTS MARKET, BY PATIENT TYPE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Adult
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Pediatric
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
CHAPTER 6: HOME REHABILITATION PRODUCTS MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Long term care centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Outpatient centers
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Medical research institutes
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- 6.6 Others
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country
CHAPTER 7: HOME REHABILITATION PRODUCTS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product type
- 7.2.3 North America Market size and forecast, by Patient type
- 7.2.4 North America Market size and forecast, by End user
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product type
- 7.2.5.1.2 Market size and forecast, by Patient type
- 7.2.5.1.3 Market size and forecast, by End user
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product type
- 7.2.5.2.2 Market size and forecast, by Patient type
- 7.2.5.2.3 Market size and forecast, by End user
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product type
- 7.2.5.3.2 Market size and forecast, by Patient type
- 7.2.5.3.3 Market size and forecast, by End user
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product type
- 7.3.3 Europe Market size and forecast, by Patient type
- 7.3.4 Europe Market size and forecast, by End user
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 UK
- 7.3.5.1.1 Market size and forecast, by Product type
- 7.3.5.1.2 Market size and forecast, by Patient type
- 7.3.5.1.3 Market size and forecast, by End user
- 7.3.5.2 Italy
- 7.3.5.2.1 Market size and forecast, by Product type
- 7.3.5.2.2 Market size and forecast, by Patient type
- 7.3.5.2.3 Market size and forecast, by End user
- 7.3.5.3 Germany
- 7.3.5.3.1 Market size and forecast, by Product type
- 7.3.5.3.2 Market size and forecast, by Patient type
- 7.3.5.3.3 Market size and forecast, by End user
- 7.3.5.4 France
- 7.3.5.4.1 Market size and forecast, by Product type
- 7.3.5.4.2 Market size and forecast, by Patient type
- 7.3.5.4.3 Market size and forecast, by End user
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product type
- 7.3.5.5.2 Market size and forecast, by Patient type
- 7.3.5.5.3 Market size and forecast, by End user
- 7.3.5.6 The Netherlands
- 7.3.5.6.1 Market size and forecast, by Product type
- 7.3.5.6.2 Market size and forecast, by Patient type
- 7.3.5.6.3 Market size and forecast, by End user
- 7.3.5.7 Switzerland
- 7.3.5.7.1 Market size and forecast, by Product type
- 7.3.5.7.2 Market size and forecast, by Patient type
- 7.3.5.7.3 Market size and forecast, by End user
- 7.3.5.8 Rest of Europe
- 7.3.5.8.1 Market size and forecast, by Product type
- 7.3.5.8.2 Market size and forecast, by Patient type
- 7.3.5.8.3 Market size and forecast, by End user
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product type
- 7.4.3 Asia-Pacific Market size and forecast, by Patient type
- 7.4.4 Asia-Pacific Market size and forecast, by End user
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Product type
- 7.4.5.1.2 Market size and forecast, by Patient type
- 7.4.5.1.3 Market size and forecast, by End user
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Product type
- 7.4.5.2.2 Market size and forecast, by Patient type
- 7.4.5.2.3 Market size and forecast, by End user
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product type
- 7.4.5.3.2 Market size and forecast, by Patient type
- 7.4.5.3.3 Market size and forecast, by End user
- 7.4.5.4 South Korea
- 7.4.5.4.1 Market size and forecast, by Product type
- 7.4.5.4.2 Market size and forecast, by Patient type
- 7.4.5.4.3 Market size and forecast, by End user
- 7.4.5.5 Australia
- 7.4.5.5.1 Market size and forecast, by Product type
- 7.4.5.5.2 Market size and forecast, by Patient type
- 7.4.5.5.3 Market size and forecast, by End user
- 7.4.5.6 Indonesia
- 7.4.5.6.1 Market size and forecast, by Product type
- 7.4.5.6.2 Market size and forecast, by Patient type
- 7.4.5.6.3 Market size and forecast, by End user
- 7.4.5.7 Thailand
- 7.4.5.7.1 Market size and forecast, by Product type
- 7.4.5.7.2 Market size and forecast, by Patient type
- 7.4.5.7.3 Market size and forecast, by End user
- 7.4.5.8 Rest of Asia-Pacific
- 7.4.5.8.1 Market size and forecast, by Product type
- 7.4.5.8.2 Market size and forecast, by Patient type
- 7.4.5.8.3 Market size and forecast, by End user
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product type
- 7.5.3 LAMEA Market size and forecast, by Patient type
- 7.5.4 LAMEA Market size and forecast, by End user
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Latin America
- 7.5.5.1.1 Market size and forecast, by Product type
- 7.5.5.1.2 Market size and forecast, by Patient type
- 7.5.5.1.3 Market size and forecast, by End user
- 7.5.5.2 Middle East
- 7.5.5.2.1 Market size and forecast, by Product type
- 7.5.5.2.2 Market size and forecast, by Patient type
- 7.5.5.2.3 Market size and forecast, by End user
- 7.5.5.3 Africa
- 7.5.5.3.1 Market size and forecast, by Product type
- 7.5.5.3.2 Market size and forecast, by Patient type
- 7.5.5.3.3 Market size and forecast, by End user
CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
CHAPTER 9: COMPANY PROFILES
- 9.1 Medline Industries, Inc.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Stryker Corporation
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Invacare Corporation
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 DJO Global
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Ekso Bionics Holdings, Inc.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 RehabCare
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Active Medical and Rehabilitation Services Pvt. Ltd.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 ergoline GmbH
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Performance Health
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Baxter International
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Arjo
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Colfax Corp
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 Dynatronics Corp.
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Handicare Group AB
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Drive DeVilbiss International
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments